Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 21, 2009 - Issue sup1
415
Views
69
CrossRef citations to date
0
Altmetric
Research Article

Engineered nanoparticle respiratory exposure and potential risks for cardiovascular toxicity: Predictive tests and biomarkers

&
Pages 68-73 | Received 27 Mar 2009, Accepted 02 Apr 2009, Published online: 30 Jun 2009

References

  • Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. 2003. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 21(2):347–360.
  • Araujo JA, Barajas B, Kleinman M, Wang X, Bennett BJ, Gong KW, et al. 2008. Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress. Circ Res. 102(5):589–596.
  • Ballinger SW. 2005. Mitochondrial dysfunction in cardiovascular disease. Free Radical Biol Med. 38(10):1278–1295.
  • Ballinger SW, Patterson C, Knight-Lozano CA, Burow DL, Conklin CA, Hu Z, et al. 2002. Mitochondrial integrity and function in atherogenesis. Circulation. 106(5):544–549.
  • Bernal-Mizrachi C, Gates AC, Weng S, Imamura T, Knutsen RH, DeSantis P, et al. 2005. Vascular respiratory uncoupling increases blood pressure and atherosclerosis. Nature. 435(7041):502–506.
  • Borm PJ, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, et al. 2006. The potential risks of nanomaterials: A review carried out for ECETOC. Part Fibre Toxicol. 3:11.
  • Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, et al. 2004. Air pollution and cardiovascular disease: A statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation. 109(21):2655–2671.
  • Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, et al. 2005. A network-based analysis of systemic inflammation in humans. Nature. 437(7061):1032–1037.
  • Chambers RC. 2008. Procoagulant signalling mechanisms in lung inflammation and fibrosis: Novel opportunities for pharmacological intervention? Br J Pharmacol. 153 Suppl 1:S367–378.
  • Colvin VL. 2003. The potential environmental impact of engineered nanomaterials. Nat Biotechnol. 21(10):1166–1170.
  • Copeland S, Warren HS, Lowry SF, Calvano SE, Remick D. 2005. Acute inflammatory response to endotoxin in mice and humans. Clin Diagn Lab Immunol. 12(1):60–67.
  • Deng JC, Standiford TJ. 2005. The systemic response to lung infection. Clin Chest Med. 26(1):1–9.
  • Donaldson K, Aitken R, Tran L, Stone V, Duffin R, Forrest G, et al. 2006. Carbon nanotubes: A review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol Sci. 92(1):5–22.
  • Erdely A, Hulderman T, Salmen R, Liston A, Zeidler-Erdely PC, Schwegler-Berry D, et al. 2009. Cross-talk between lung and systemic circulation during carbon nanotube respiratory exposure. Potential biomarkers Nano Lett. 9(1):36–43.
  • Erdely A, Salmen R, Chapman R, Hulderman T, Simeonova PP. 2007. Lung inflammation and cardiovascular outcomes—whole blood gene expression studies in a lipopolysaccharide (LPS) pharyngeal aspiration mouse model. Toxicologists 96(1):68.
  • Fimognari FL, Scarlata S, Conte ME, Incalzi RA. 2008. Mechanisms of atherothrombosis in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 3(1):89–96.
  • Fischer LM, Schlienger RG, Matter C, Jick H, Meier CR. 2004. Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am J Cardiol. 93(2): 198–200.
  • Gojova A, Guo B, Kota RS, Rutledge JC, Kennedy IM, Barakat AI. 2007. Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: Effect of particle composition. Environ Health Perspect. 115(3):403–409.
  • Heckel K, Kiefmann R, Dorger M, Stoeckelhuber M, Goetz AE. 2004. Colloidal gold particles as a new in vivo marker of early acute lung injury. Am J Physiol Lung Cell Mol. Physiol 287(4):L867–878.
  • Hollan I, Scott H, Saatvedt K, Prayson R, Mikkelsen K, Nossent HC, et al. 2007. Inflammatory rheumatic disease and smoking are predictors of aortic inflammation: A controlled study of biopsy specimens obtained at coronary artery surgery. Arthritis Rheum. 56(6):2072–2079.
  • Hood E. 2004. Nanotechnology: Looking as we leap. Environ Health Perspect. 112(13):A740–749.
  • Kato T, Yashiro T, Murata Y, Herbert DC, Oshikawa K, Bando M, et al. 2003. Evidence that exogenous substances can be phagocytized by alveolar epithelial cells and transported into blood capillaries. Cell Tissue Res. 311(1):47–51.
  • Kunzli N, Schindler C. 2005. Case-crossover studies. Epidemiology. 16(4):592–593; author reply 593.
  • Kurahashi K, Kajikawa O, Sawa T, Ohara M, Gropper MA, Frank DW, et al. 1999. Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J Clin Invest. 104(6):743–750.
  • Lam CW, James JT, McCluskey R, Hunter RL. 2004. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci. 77(1):126–134.
  • Li JG, Li WX, Xu JY, Cai XQ, Liu RL, Li YJ, et al. 2007. Comparative study of pathological lesions induced by multiwalled carbon nanotubes in lungs of mice by intratracheal instillation and inhalation. Environ Toxicol. 22(4):415–421.
  • Li Z, Hulderman T, Salmen R, Chapman R, Leonard SS, Young SH, et al. 2007. Cardiovascular effects of pulmonary exposure to single-wall carbon nanotubes. Environ Health Perspect. 115(3):377–382.
  • Libby P. 2002. Inflammation in atherosclerosis. Nature. 420(6917):868–874.
  • Libby P. 2006. Atherosclerosis: Disease biology affecting the coronary vasculature. Am J Cardiol. 98(12A):3Q–9Q.
  • Libby P, Hansson GK, Pober J. 1999. Atherogenesis and inflammation. In: Molecular basis of cardiovascular disease. (Chien KR, ed). Philadelphia: W.B. Saunders, 349–366.
  • Mangum JB, Turpin EA, Antao-Menezes A, Cesta MF, Bermudez E, Bonner JC. 2006. Single-walled carbon nanotube (SWCNT)-induced interstitial fibrosis in the lungs of rats is associated with increased levels of PDGF mRNA and the formation of unique intercellular carbon structures that bridge alveolar macrophages in situ. Part Fibre Toxicol. 3:15.
  • Mannino DM, Thorn D, Swensen A, Holguin F. 2008. Prevalence and outcomes of diabetes, hypertension, and cardiovascular disease in chronic obstructive pulmonary disease. Eur Respir J. 32(4):962–969.
  • Mercer RR, Scabilloni J, Wang L, Kisin E, Murray AR, Schwegler-Berry D, et al. 2008. Alteration of deposition pattern and pulmonary response as a result of improved dispersion of aspirated single-walled carbon nanotubes in a mouse model. Am J Physiol Lung Cell Mol Physiol. 294(1):L87–97.
  • Miller KA, Siscovick DS, Sheppard L, Shepherd K, Sullivan JH, Anderson GL, et al. 2007. Long-term exposure to air pollution and incidence of cardiovascular events in women. N Engl J Med. 356(5):447–458.
  • Mills NL, Miller JJ, Anand A, Robinson SD, Frazer GA, Anderson D, et al. 2008. Increased arterial stiffness in patients with chronic obstructive pulmonary disease: A mechanism for increased cardiovascular risk. Thorax. 63(4):306–311.
  • Mills NL, Oberdorster G, Newby DE. 2008. Reducing exposure to airborne particles: A novel strategy to improve cardiovascular health. Am J Respir Crit Care Med. 177(4):366–367.
  • Mills NL, Tornqvist H, Robinson SD, Gonzalez M, Darnley K, MacNee W, et al. 2005. Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation. 112(25):3930–3936.
  • Mills NL, Tornqvist H, Robinson SD, Gonzalez MC, Soderberg S, Sandstrom T, et al. 2007. Air pollution and atherothrombosis. Inhal Toxicol. 19 Suppl 1:81–89.
  • Moller W, Felten K, Sommerer K, Scheuch G, Meyer G, Meyer P, et al. 2008. Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery. Am J Respir Crit Care Med. 177(4):426–432.
  • Muller J, Huaux F, Moreau N, Misson P, Heilier JF, Delos M, et al. 2005. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol Appl Pharmacol. 207(3):221–231.
  • Nemmar A, Hoet PH, Vandervoort P, Dinsdale D, Nemery B, Hoylaerts MF. 2007. Enhanced peripheral thrombogenicity after lung inflammation is mediated by platelet-leukocyte activation: role of P-selectin. J Thromb Haemost. 5(6):1217–1226.
  • Oberdorster G, Oberdorster E, Oberdorster J. 2005. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 113(7):823–839.
  • Park KH, Chhowalla M, Iqbal Z, Sesti F. 2003. Single-walled carbon nanotubes are a new class of ion channel blockers. J Biol Chem. 278(50):50212–50216.
  • Pope CA, 3rd, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D, et al. 2004. Cardiovascular mortality and long-term exposure to particulate air pollution: Epidemiological evidence of general pathophysiological pathways of disease. Circulation. 109(1):71–77.
  • Prawan A, Kundu JK, Surh YJ. 2005. Molecular basis of heme oxygenase-1 induction: Implications for chemoprevention and chemoprotection. Antioxid Redox Signal. 7(11–12):1688–1703.
  • Quinton LJ, Nelson S, Zhang P, Boe DM, Happel KI, Pan W, et al. 2004. Selective transport of cytokine-induced neutrophil chemoattractant from the lung to the blood facilitates pulmonary neutrophil recruitment. Am J Physiol Lung Cell Mol Physiol. 286(3):L465–472.
  • Radomski A, Jurasz P, Alonso-Escolano D, Drews M, Morandi M, Malinski T, et al. 2005. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol. 146(6):882–893.
  • Raja PM, Connolley J, Ganesan GP, Ci L, Ajayan PM, Nalamasu O, et al. 2007. Impact of carbon nanotube exposure, dosage and aggregation on smooth muscle cells. Toxicol Lett. 169(1):51–63.
  • Ross R. 1999. Atherosclerosis is an inflammatory disease. Am Heart J. 138(5 Pt 2):S419–420.
  • Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, et al. 2005. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol. 289(5):L698–708.
  • Simeonova PP, Erdely A, Li Z. 2007. Carbon Nanotube Exposure and Risk for Cardiovascular Effects. New York: Informa Healthcare USA.
  • Simeonova PP, Luster MI. 2004. Arsenic and atherosclerosis. Toxicol Appl Pharmacol. 198(3):444–449.
  • Sun Q, Wang A, Jin X, Natanzon A, Duquaine D, Brook RD, et al. 2005. Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. J Am Med Assoc. 294(23):3003–3010.
  • Tornqvist H, Mills NL, Gonzalez M, Miller MR, Robinson SD, Megson IL, et al. 2007. Persistent endothelial dysfunction in humans after diesel exhaust inhalation. Am J Respir Crit Care Med. 176(4):395–400.
  • van Eeden SF, Tan WC, Suwa T, Mukae H, Terashima T, Fujii T, et al. 2001. Cytokines involved in the systemic inflammatory response induced by exposure to particulate matter air pollutants (PM(10)). Am J Respir Crit Care Med. 164(5):826–830.
  • Warheit DB, Laurence BR, Reed KL, Roach DH, Reynolds GA, Webb TR. 2004. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci. 77(1):117–125.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.